Literature DB >> 8457468

Transcriptional and post-transcriptional regulation of IL-1 beta, IL-6 and TNF-alpha genes in chronic lymphocytic leukaemia.

A Rambaldi1, S Bettoni, V Rossi, M L Tini, G Giudici, V Rizzo, R Bassan, A Mantovani, T Barbui, A Biondi.   

Abstract

The present study was designed to define the mechanisms of interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6) and tumour necrosis factor (TNF-alpha) gene regulation in chronic lymphocytic leukaemia of B cell origin (B-CLL). By nuclear run-on analysis, all B-CLL cases displayed high levels of nuclear transcription of the IL-6 and TNF-alpha genes, whereas IL-1 beta gene transcription was only barely detectable. Upon in vitro culture for 1 h, B-CLL cells from different patients were substantially heterogeneous in terms of expression of steady state mRNA levels of IL-1 beta, IL-6 and TNF-alpha even though the pattern of nuclear transcription of these cytokines was only marginally affected by in vitro culture. mRNA stability was then examined and cytokine gene transcripts showed a half life of more than 2 h in cultured B-CLL cells and treatment with cycloheximide (CHX) did not affect cytokine transcript levels in B-CLL cells. These results indicate that: steady state levels of each mRNA do not reflect the rate of nuclear transcription of these cytokines in fresh or cultured B-CLL cells, that purification and in vitro culture of leukaemic cells may amplify cytokine gene expression in B-CLL, and that cytokine gene transcripts are relatively stable in B-CLL.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457468     DOI: 10.1111/j.1365-2141.1993.tb08273.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  miR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-kappaB.

Authors:  Zheng Xu; Shao-Bo Xiao; Peng Xu; Qian Xie; Lu Cao; Dang Wang; Rui Luo; Yao Zhong; Huan-Chun Chen; Liu-Rong Fang
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  Cytokines in the pathophysiology and treatment of chronic B-cell malignancies. A review.

Authors:  M Schuler; C Huber; C Peschel
Journal:  Ann Hematol       Date:  1995-08       Impact factor: 3.673

3.  Tumor necrosis factor alpha, interleukin 1 alpha, and interleukin 6 mRNA expressed by human astrocytoma cells after infection by three different strains of Toxoplasma gondii.

Authors:  H Pelloux; J Ricard; V Bracchi; Y Markowicz; J M Verna; P Ambroise-Thomas
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

4.  Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.

Authors:  T Robak; A Wierzbowska; M Błasińska-Morawiec; A Korycka; J Z Błoński
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

5.  Cytokine mRNA and protein expression in primary-culture and repeated-passage synovial fibroblasts from patients with rheumatoid arthritis.

Authors:  Astrid Hirth; Alla Skapenko; Raimund W Kinne; Frank Emmrich; Hendrik Schulze-Koops; Ulrich Sack
Journal:  Arthritis Res       Date:  2001-11-08

6.  Inhibition of IL-6 signaling pathway by curcumin in uterine decidual cells.

Authors:  Y Sangeeta Devi; Majesta DeVine; Justin DeKuiper; Susan Ferguson; Asgerally T Fazleabas
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

7.  Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages.

Authors:  Xiaoxuan Zhang; Guangji Wang; Emily C Gurley; Huiping Zhou
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

8.  miR-146b-5p mediates p16-dependent repression of IL-6 and suppresses paracrine procarcinogenic effects of breast stromal fibroblasts.

Authors:  Mysoon M Al-Ansari; Abdelilah Aboussekhra
Journal:  Oncotarget       Date:  2015-10-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.